These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
547 related articles for article (PubMed ID: 15150114)
1. Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor. Givant-Horwitz V; Davidson B; Reich R Cancer Res; 2004 May; 64(10):3572-9. PubMed ID: 15150114 [TBL] [Abstract][Full Text] [Related]
2. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation. Hutter D; Chen P; Barnes J; Liu Y Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068 [TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation. Fürst R; Brueckl C; Kuebler WM; Zahler S; Krötz F; Görlach A; Vollmar AM; Kiemer AK Circ Res; 2005 Jan; 96(1):43-53. PubMed ID: 15569826 [TBL] [Abstract][Full Text] [Related]
4. Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway. Xu Q; Konta T; Nakayama K; Furusu A; Moreno-Manzano V; Lucio-Cazana J; Ishikawa Y; Fine LG; Yao J; Kitamura M Free Radic Biol Med; 2004 Apr; 36(8):985-93. PubMed ID: 15059639 [TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients. Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070 [TBL] [Abstract][Full Text] [Related]
6. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells. Franklin CC; Kraft AS Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188 [TBL] [Abstract][Full Text] [Related]
7. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. Groom LA; Sneddon AA; Alessi DR; Dowd S; Keyse SM EMBO J; 1996 Jul; 15(14):3621-32. PubMed ID: 8670865 [TBL] [Abstract][Full Text] [Related]
9. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells. Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938 [TBL] [Abstract][Full Text] [Related]
10. Retinoic acid inhibits hepatic Jun N-terminal kinase-dependent signaling pathway in ethanol-fed rats. Chung J; Chavez PR; Russell RM; Wang XD Oncogene; 2002 Feb; 21(10):1539-47. PubMed ID: 11896582 [TBL] [Abstract][Full Text] [Related]
11. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases. Sprowles A; Robinson D; Wu YM; Kung HJ; Wisdom R Exp Cell Res; 2005 Aug; 308(2):459-68. PubMed ID: 15950217 [TBL] [Abstract][Full Text] [Related]
12. Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells. Wang Z; Yang H; Tachado SD; Capó-Aponte JE; Bildin VN; Koziel H; Reinach PS Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5267-75. PubMed ID: 17122112 [TBL] [Abstract][Full Text] [Related]
13. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. Magi-Galluzzi C; Mishra R; Fiorentino M; Montironi R; Yao H; Capodieci P; Wishnow K; Kaplan I; Stork PJ; Loda M Lab Invest; 1997 Jan; 76(1):37-51. PubMed ID: 9010448 [TBL] [Abstract][Full Text] [Related]
14. Triptolide suppresses interleukin-1beta-induced human beta-defensin-2 mRNA expression through inhibition of transcriptional activation of NF-kappaB in A549 cells. Jang BC; Lim KJ; Choi IH; Suh MH; Park JG; Mun KC; Bae JH; Shin DH; Suh SI Int J Mol Med; 2007 May; 19(5):757-63. PubMed ID: 17390080 [TBL] [Abstract][Full Text] [Related]
15. Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models. Reddy ST; Nguyen JT; Grijalva V; Hough G; Hama S; Navab M; Fogelman AM Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1676-81. PubMed ID: 15242861 [TBL] [Abstract][Full Text] [Related]
16. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death. Zhou JY; Liu Y; Wu GS Cancer Res; 2006 May; 66(9):4888-94. PubMed ID: 16651445 [TBL] [Abstract][Full Text] [Related]
17. Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance. Small GW; Shi YY; Higgins LS; Orlowski RZ Cancer Res; 2007 May; 67(9):4459-66. PubMed ID: 17483361 [TBL] [Abstract][Full Text] [Related]
18. [A study on the regulatory mechanisms of mitogen-activated protein kinase phosphatase-1 in hypoxia inducible factor-1 trans-activation]. Qiao TD; Liu CJ; Shi YQ; DU YL; Han S; Fan DM Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):555-9. PubMed ID: 15949338 [TBL] [Abstract][Full Text] [Related]
19. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways. Ruhul Amin AR; Oo ML; Senga T; Suzuki N; Feng GS; Hamaguchi M Cancer Res; 2003 Oct; 63(19):6334-9. PubMed ID: 14559821 [TBL] [Abstract][Full Text] [Related]
20. Osmotic regulation of insulin-induced mitogen-activated protein kinase phosphatase (MKP-1) expression in H4IIE rat hepatoma cells. Lornejad-Schäfer MR; Schäfer C; Graf D; Häussinger D; Schliess F Biochem J; 2003 Apr; 371(Pt 2):609-19. PubMed ID: 12529177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]